4//SEC Filing
OConnell Daniel Joseph 4
Accession 0001209191-22-004419
CIK 0001576885other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:20 PM ET
Size
5.5 KB
Accession
0001209191-22-004419
Insider Transaction Report
Form 4
OConnell Daniel Joseph
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-19+455,000→ 455,000 totalExercise: $5.19Exp: 2032-01-19→ Common Stock (455,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001865136
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:20 PM ET
- Size
- 5.5 KB